SFX by Ex Libris Inc.

Title:	Translational Modeling in Schizophrenia: Predicting Human Dopamine D2 Receptor Occupancy
Source:	Pharmaceutical Research [0724-8741] Johnson, Martin yr:2015

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Siegel, Steven J. "Mice with subtle reduction of NMDA NR1 receptor subunit expression have a selective decrease in mismatch negativity: Implications for schizophrenia prodromal population." Neurobiology of disease 73C (2014): 289-295.
description	2.	Paintaud, G. "Mechanism-based pharmacokinetic-pharmacodynamic modeling - A new classification of biomarkers." Pharmaceutical research 22.9 (2005): 1432-7.
description	3.	Danhof, M. "Mechanism-based pharmacokinetic-pharmacodynamic modeling: Biophase distribution, receptor theory, and dynamical systems analysis." Annual review of pharmacology and toxicology 47.1 (2007): 357-400.
description	4.	Muller, Johan W W. "Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes." American journal of obstetrics and gynecology 198.1 (2007): 108-6.
description	5.	Atkinson, Jr. J. "Biomarkers and surrogate endpoints: preferred definitions and conceptual framework." Clinical pharmacology and therapeutics 69.3 (2001): 89-95.
description	6.	Lau, D. "BDNF Reduces Toxic Extrasynaptic NMDA Receptor Signaling via Synaptic NMDA Receptors and Nuclear-Calcium-Induced Transcription of inhba/Activin A." Cell Reports 12.8 (2015): 1353-1366.
description	7.	Nakane, M. "2-[4-(3,4-Dimethylphenyl)piperazin-l-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D-4 receptor antagonist." Neuropharmacology 49.1 (2005): 112-121.
description	8.	Ravna, A. "Molecular Mechanism of Citalopram and Cocaine Interactions with Neurotransmitter Transporters." The Journal of pharmacology and experimental therapeutics 307.1 (2003): 34-41.
description	9.	Schoepp, Darryle D Y. "Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial." Nature medicine 13.9 (2007): 1102-7.
description	10.	Danhof, M. "Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research." Trends in Pharmacological Sciences 29.4 (2008): 186-91.
description	11.	Belforte, Juan E. "Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes." Nature Neuroscience 13.1 (2010): 76-83.
description	12.	Jonker, Daniel M. M. "Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo." Pharmacology & therapeutics 106.1 (2005): 1-18.
description	13.	Muller, Anouk E E. "Pharmacokinetics of penicillin G in infants with a gestational age of less than 32 weeks." Antimicrobial agents and chemotherapy 51.10 (2007): 3720-5.
description	14.	Post, T. "Disease system analysis: basic disease progression models in degenerative disease." Pharmaceutical Research 22.7 (2005): 1038-49.
description	15.	Audus, K L L. "Controlling drug delivery across the placenta." European journal of pharmaceutical sciences 8.3 (1999): 161-5.
description	16.	Danhof, M. "The pharmacokinetics of clindamycin in pregnant women in the peripartum period." Antimicrobial agents and chemotherapy (2010).
description	17.	Müller, M C A C. "[A young woman from Cameroon with rectal blood loss, intestinal schistosomiasis and rectosigmoid carcinoma]." Nederlands tijdschrift voor geneeskunde (2008): 951-5.
description	18.	Gillette, Michael A A. "Place of pattern in proteomic biomarker discovery." Journal of proteome research 4.4 (2005): 1143-1154.
description	19.	Rorick-Kehn, Linda M M. "In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders." Psychopharmacology 193.1 (2007): 121-36.
description	20.	González-Maeso, J. "Identification of a serotonin/glutamate receptor complex implicated in psychosis." Nature 452.7183 (2008): 93-7.